FluroTech Ltd. (FLURF)
Stock analysis · OTC · Healthcare · Medical - Devices
$0.00
Market Cap
$447.18K
PE (TTM)
-2.33
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
-0.44
Day Range
$0.00 – $0.00
52-wk Range
$0.00 – $0.00
Avg Volume
N/A
Volume
0.00
FluroTech Ltd. (FLURF) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $447.18K. Trailing PE -2.33. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Proprietary Signals
About FluroTech Ltd.
FluroTech Ltd. operates as a technology and marketing firm, primarily focused on advancing and commercializing various innovations within the pandemic defense industry. The company is responsible for developing the FluroTest SARS-CoV-2 diagnostic, which is designed to pinpoint patients with active viral infections. Its headquarters are located in Calgary, Canada.
Valuation
| P/E (TTM) | -2.33× |
|---|---|
| P/S (TTM) | 0.00× |
| P/B | -1.40× |
| PEG | 0.00× |
| P/FCF (TTM) | -4.17× |
| EV / EBITDA | 17.03× |
| EV / Sales | 0.00× |
| Earnings Yield | -42.24% |
| Free Cash Flow Yield | -23.95% |
Fundamentals
| Enterprise Value | $549.56K |
|---|---|
| Net Income (TTM) | -$264.31K |
| Free Cash Flow (TTM) | -$149.90K |
| Net Debt | -$76.19K |
| Working Capital | -$180.35K |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | 80.08% |
| Return on Invested Capital | 299.44% |
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap